Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 193
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00903214 | Riluzole in Women With Stage I, Stage II, or Stage IIIA Breast Cancer | ||
| NCT00068653 | Gefitinib and Celecoxib in Treating Patients With Refractory Non-Small Cell Lung Cancer | ||
| NCT01416961 | Integration of Neutron Therapy in the Treatment Plan for Stage III Non-Small Cell Lung Cancer (NSCLC) | ||
| NCT03684005 | MyPatientPal: An App to Help Patients Manage Their Cancer Care | ||
| NCT00376948 | Genistein, Gemcitabine, and Erlotinib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | ||
| NCT07042191 | A Provider Intervention to Reduce Financial Toxicity in Patients With Cancer Through Improved Treatment Cost Discussions | ||
| NCT00003250 | Fenretinide in Treating Patients With Solid Tumors | ||
| NCT00423826 | Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease | ||
| NCT00520767 | Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease | ||
| NCT00020722 | Chemotherapy Followed by Peripheral Stem Cell Transplantation Plus Biological Therapy in Treating Women With Stage IV Breast Cancer | ||
| NCT00002552 | Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma | ||
| NCT00369109 | Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid Tumors | ||
| NCT05738005 | Dietary Reporting In The Amyloidoses | ||
| NCT00499694 | Satraplatin and Bevacizumab in Treating Patients With Metastatic Prostate Cancer Previously Treated With Docetaxel | ||
| NCT00003171 | Bryostatin 1 in Treating Patients With Myelodysplastic Syndrome | ||
| NCT01468532 | Docetaxel, Prednisone, and Pasireotide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer | ||
| NCT02269267 | The Life After Stopping Tyrosine Kinase Inhibitors Study (The LAST Study) | ||
| NCT00268255 | Gefitinib and Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer | ||
| NCT07227831 | A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast Cancer | ||
| NCT00030420 | Celecoxib and Docetaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer | ||
| NCT00002923 | KRN5500 in Treating Patients With Metastatic Solid Tumors | ||
| NCT06439914 | First-in-human Study of Interferon-y PET Imaging to Assess Response to Immunotherapy | ||
| NCT03406858 | Pembro and HER2Bi-Armed Activated T Cells in Treating Patients With Metastatic Castration Resistant Prostate Cancer | ||
| NCT03657511 | Tobacco Cessation Intervention | ||
| NCT02207010 | A Phase 0 Study of AZD1775 in Recurrent GBM Patients | ||
| NCT00002907 | Bryostatin 1 in Treating Patients With Relapsed Multiple Myeloma | ||
| NCT00305747 | Diindolylmethane in Treating Patients With Nonmetastatic Prostate Cancer That Has Not Responded To Previous Hormone Therapy | ||
| NCT01534143 | High Dose Busulfan and Bortezomib in Treating Patients With High Risk Multiple Myeloma Undergoing Stem Cell Transplant | ||
| NCT01643603 | Dasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic Malignancies | ||
| NCT01958372 | Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer | ||
| NCT03683420 | Music in Reducing Distress in Participants with Cancer During Chemotherapy Treatment | ||
| NCT02372877 | Evaluation of the AMICUS RBCx System in Sickle Cell Patients | ||
| NCT00227721 | Gemcitabine and Docetaxel in Treating Patients With Relapsed or Refractory Ovarian Epithelial or Peritoneal Cancer | ||
| NCT06537687 | Relational Agents in Cervical Cancer Education (RACE) | ||
| NCT00052403 | Monoclonal Antibody Therapy in Treating Patients With Advanced Solid Tumors | ||
| NCT00258310 | Ph II Long Term/Low Dose Xeloda in Head and Neck Squamous Cell Carcinoma After Surgery, Radiation & or Chemo | ||
| NCT01415089 | Tailored Web-Based Intervention for Cancer Patients and Family Caregivers | ||
| NCT00003936 | Bryostatin 1 in Treating Patients With Recurrent or Refractory Hodgkin's Disease | ||
| NCT00120029 | Peer Counseling for Weight Loss | ||
| NCT00003174 | Bryostatin 1 Plus Cladribine in Treating Patients With Relapsed Chronic Lymphocytic Leukemia | ||
| NCT05025748 | Ask Questions (ASQ):Implementation of a Communication Intervention | ||
| NCT06501040 | Increasing Knowledge and Interest in Cancer Clinical Trials | ||
| NCT02058706 | LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Hormone Sensitive Prostate Cancer | ||
| NCT03421652 | Nivolumab and RT in Treating Patients With Localized/Locally Advanced Urothelial Bladder Cancer Ineligible for Chemo | ||
| NCT00004144 | Bryostatin 1 Plus Gemcitabine in Treating Patients With Advanced Cancer | ||
| NCT01888198 | Ablation of Renal Masses Outcomes Registry (ARMOR): Ablation Procedure and Quality of Life Assessment | ||
| NCT00938626 | Treated T Cells Followed by a Stem Cell Transplant in Treating Patients With Multiple Myeloma | ||
| NCT02568449 | Nintedanib in Treating Patients With Malignant Pleural Mesothelioma That Is Recurrent | ||
| NCT00960427 | Studying Biomarkers in Tumor Tissue and Blood Samples From Patients Undergoing Chemotherapy and Radiation Therapy for Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery | ||
| NCT00503841 | Erlotinib in Treating Women Undergoing Surgery For Stage I, Stage II, or Stage III Breast Cancer |
